web analytics

GMP vs Listing Gains: A Data Analysis of 17 IPOs Listed in February 2026

In February 2026, a total of 17 IPOs got listed, out of which 3 IPOs belong to mainboard and 14 IPOs belong to SME section.

This report analyses how the Mainboard and SME IPOs got listed in comparison to their reported GMPs (grey market premiums).

For current live IPOs, check our dedicated GMP section which is updated regularly. 

*GMP is unofficial and is not regulated by either SEBI/NSE/BSE. 

SME IPOs vs Mainboard IPOs listed in February 2026 in Nos

GMP Vs Listing Performance February 2026 IPOs.

SL NoIPO NAMEMainboard/SMEPRICEFinal GMPListing Price% Gain/lossGMP Outcome
1Gaudium IVF and Women Health LimitedMainboard₹75 – ₹790835.06Listed above GMP expectations.
2Manilam Industries India LimitedNSE SME₹65 – ₹69055.2-20Listed below GMP expectations
3Yashhtej Industries (India) LimitedBSE SME₹110088-20Listed below GMP expectations
4Fractal Industries LimitedBSE SME₹205 – ₹21682296.02Listed above GMP expectations
5Marushika Technology LimitedNSE SME₹111 – ₹11721202.56Listed above GMP expectations
6Fractal Analytics LimitedMainboard₹857 – ₹900-28876-2.7Listed above GMP expectations
7Aye Finance LimitedMainboard₹122 – ₹129-21290Listed above GMP expectations
8Biopol Chemicals LimitedNSE SME₹102 – ₹10811112.78Listed above GMP expectations
9PAN HR Solution LimitedBSE SME₹74 – ₹78078.350.45Listed above GMP expectations
10Brandman Retail LimitedNSE SME₹167 – ₹176171833.98Listed below GMP expectations
11Grover Jewells LimitedNSE SME₹83 – ₹880969.09Listed above GMP expectations
12C K K Retail Mart LimitedNSE SME₹155 – ₹16301630Listed in line with GMP expectation.
13Msafe Equipments LimitedBSE SME₹116 – ₹1232114417.07Listed in line with GMP expectations
14Kanishk Aluminium India LimitedBSE SME₹73058.4-20Listed below GMP expectations
15Accretion Nutraveda LimitedBSE SME₹122 – ₹1296819148.06Listed below GMP expectations
16Kasturi Metal Composite LimitedBSE SME₹61 – ₹642640Listed below GMP expectations
17Hannah Joseph Hospital Limited (HJHL)BSE SME₹67 – ₹70265-7.1Listed below expectations

GMP accuracy distribution  February 2026: mainboard IPOs.

Mainboard IPO- 3

Listed Above GMP expectation: 3

Listed Below GMP expectation: 0

Listed in line with GMP expectation: 0

Mainboard IPO: Avg GMP % vs Avg listing % February 2026 IPOs

GMP Vs Listing Performance of Mainboard IPOs of Feb 2026

Avg GMP of mainboard IPOs is -1.55% while avg listing gain is only 0.786%, indicating weak grey market sentiment and muted listing performance.

GMP accuracy distribution February 2026: SME IPOs

SME IPOs: 14

Listed Above GMP expectation: 5

Listed Below GMP expectation: 7

Listed in line with GMP expectation: 2

GMP Accuracy distribution SME IPOs February 2026

SME IPOs- Avg GMP % Vs Avg Listing % 

February 2026 IPOs

 Avg GMP% of SME IPOs- 6.6%

Avg listing % of SME IPOs- 1.64%

GMP Vs Listing Performance of SME IPOs of Feb 2026

SME IPOs show strong grey market optimism with avg GMP at 6.6%, but actual listing gains average only 1.64%.

IPO-wise Detailed Commentary ON IPO GMP February 2026

1. Hannah Joseph Hospital Limited (HJHL) GMP Vs Listing

Hannah Joseph Hospital Limited (HJHL) had a GMP of ₹0 and now it has gone up to 2, indicating positive sentiment in the grey market. Let us see how this unfolds over time.

Hannah Joseph Hospital Limited (HJHL) finally got listed at ₹65, or ₹5 below the issue price of ₹70, which is a 7.14% discount to the issue price. The GMP was ₹2, or 2.86% above the issue price. The issue listed below GMP expectations.

2. Accretion Nutraveda Limited GMP Vs Listing

Accretion Nutraveda Limited had 0 GMP which moved to 3 Rs and then to 4 Rs and then from 4 Rs to 6 Rs and then to 10 and then from 10 to 17 indicating positive sentiment in the grey market. (0→3→4→6→10→17→32→55→68).

Accretion Nutraveda Limited finally got listed at ₹191, or ₹62 above the issue price of ₹129, translating into a 48.06% listing premium.The GMP was ₹68, indicating an expected premium of around 52.71%. The issue listed largely in line with GMP expectations.

3. Kasturi Metal Composite Limited GMP Vs Listing

Kasturi Metal Composite Limited had no reported GMP but now the GMP has moved to 2 indicating postive sentiment in the grey market. Kasturi Metal Composite Limited upper band issue price was ₹64, and the stock finally got listed at ₹64, resulting in no listing gain over the issue price (a 0% premium). It got listed below GMP expectations.

4. NFP Sampoorna Foods Limited GMP Vs Listing

NFP Sampoorna Foods Limited has no reported GMP indicating neutral sentiment in the grey market. (withdrawn).

5. Msafe Equipments Limited GMP Vs Listing

Msafe Equipments Limited finally got listed at ₹144, or ₹21 above the issue price of ₹123, translating into a 17.07% premium to the issue price.The GMP was ₹21, indicating an expected premium of around 17.07%.The issue listed in line with GMP expectations.

6. C K K Retail Mart Limited GMP Vs Listing

C K K Retail Mart Limited has no reported GMP indicating neutral sentiment in the grey market. 

C K K Retail Mart Limited finally got listed at ₹163, in line with the issue price of ₹163, implying a 0% listing premium.
The GMP was ₹0, or 0% above the issue price, and the issue listed in line with GMP expectations.

7. Kanishk Aluminium India Limited GMP Vs Listing

Kanishk Aluminium India Limited had GMP of 3 indicating positive sentiment in the grey market but it had gone down to 0 showing now neutral market sentiment. Kanishk Aluminium India Limited finally got listed at ₹58.40, or ₹14.60 below the issue price of ₹73, translating into a 19.99% discount to the issue price.The GMP was ₹0, indicating expectations of a flat listing.The issue listed below GMP expectations.

8. Grover Jewells Limited GMP Vs Listing

Grover Jewells Limited finally got listed at ₹96, or ₹8 above the issue price of ₹88, which is a 9.09% premium to the issue price.

The GMP was ₹0, or 0% above the issue price.The issue listed above GMP expectations.

09. Brandman Retail Limited GMP Vs Listing

Brandman Retail Limited finally got listed at ₹183, or ₹7 above the issue price of ₹176, which is a 3.98% premium to the issue price. The GMP was ₹17, or 9.66% above the issue price.The issue listed below GMP expectations.

10. PAN HR Solution Limited GMP Vs Listing

PAN HR Solution Limited finally got listed at ₹78.35, or ₹0.35 above the issue price of ₹78, which is a 0.45% premium to the issue price. The GMP was ₹0, or 0% above the issue price. The issue listed above GMP expectations.

11.  Fractal Analytics Limited GMP Vs Listing

Fractal Analytics Limited finally got listed at ₹876, or ₹24 below the issue price of ₹900, which is a 2.67% discount to the issue price. The GMP was ₹-28, or -3.11% below the issue price. The issue listed above GMP expectations.

GMP movement during the period remained highly volatile, trending down from strong positive levels of ₹180–₹197 in the early phase to negative territory near listing, eventually closing at ₹-28 before debut. GMP Trend (180→182→197→105→78→57→80→61→43→40→46→28→20→10→13→21→10→8→4→7→5→(-2)→1→2→0→(-5)→(-10)→(-23)→(-13)→(-17)→(14)→(-12)→(-11)→(-28)).

12. Aye Finance Limited GMP Vs Listing

Aye Finance Limited finally got listed at ₹129, which is at par with the upper band issue price of ₹129, reflecting a 0% listing premium to the issue price. The GMP was ₹-2, or approximately 1.55% below the issue price. The issue listed above GMP expectations. GMP trend (5→4→1→0→0.35→(-3)→(-2)). 

13. Biopol Chemicals Limited GMP Vs Listing

Biopol Chemicals Limited finally got listed at ₹111, or ₹3 above the issue price of ₹108, which is a 2.78% premium to the issue price. The GMP was ₹1, or 0.93% above the issue price. The issue listed above GMP expectations. GMP movement during the period remained volatile at ₹0 → ₹3 → ₹4 → ₹1, indicating mild grey market interest ahead of listing.

14. Fractal Industries Limited GMP Vs Listing

Fractal Industries Limited finally got listed at ₹229, or ₹13 above the issue price of ₹216, which is a 6.02% premium to the issue price. The GMP was ₹8, or 3.70% above the issue price.The issue listed above GMP expectations. GMP movement during the period remained volatile at ₹7→₹5→₹4→₹0→₹5→₹8.

15. Yashhtej Industries (India) Limited GMP Vs Listing

Yashhtej Industries (India) Limited finally got listed at ₹88, or ₹22 below the issue price of ₹110, which is a 20% discount to the issue price.The GMP had cooled down to ₹0 (neutral) before listing. Earlier, GMP movement showed a sharp decline (₹23 → ₹15 → ₹1 → ₹0), indicating weakening sentiment in the grey market ahead of debut. Since the GMP was neutral and the stock listed at a significant discount, the issue listed below GMP expectations.

16. Marushika Technology Limited GMP Vs Listing

Marushika Technology Limited finally got listed at ₹120, or ₹3 above the issue price of ₹117, which is a 2.56% premium to the issue price. The GMP was ₹2, or 1.71% above the issue price. The issue listed above GMP expectations.

17. Gaudium IVF and Women Health Limited GMP Vs Listing

Gaudium IVF and Women Health Limited finally got listed at ₹83, or ₹4 above the issue price of ₹79, which is a 5.06% premium to the issue price.The GMP moved from ₹4 → ₹13 → ₹15 → ₹12 → ₹10 → ₹8.5 → ₹8 → ₹7.5 → ₹5 → ₹0 → (-₹4) → (-₹2) → ₹0 during the period, showing a sharp rise initially followed by a steady decline into negative territory before turning neutral. At listing, the effective GMP was near ₹0, while the stock debuted at a ₹4 premium.The issue listed above GMP expectations.

18. Manilam Industries India Limited GMP Vs Listing

Manilam Industries Limited finally got listed at ₹55.2, or ₹13.8 below the issue price of ₹69, which is a 20.00% discount to the issue price.The GMP was ₹0 (neutral), or 0% above the issue price.The issue listed below GMP expectations.

Conclusion:

The February 2026 IPO data shows a clear gap between GMP expectations and actual listing performance.

Mainboard IPOs showed weak grey market sentiment (Avg GMP -1.55%) and muted listing gains (0.78%), despite all three listings exceeding GMP expectations.

In contrast, SME IPOs reflected stronger GMP optimism (6.6%), but actual listing gains averaged only 1.64%, with half of the IPOs listing below GMP expectations.

Overall, the data suggests that GMP was not a consistently reliable predictor of listing gains, particularly in the SME segment.

Important IPO Resources:

1. IPO Calendar (Live & Upcoming Issues)

Track all current and upcoming IPOs with key dates, issue sizes, and subscription timelines.

2. IPO Analytics & Research- Check how IPOs perform post listing with trends and studies.

3. GMP vs Listing Accuracy Study 2026-A detailed study comparing Grey Market Premium (GMP) vs actual listing performance across IPOs.

4. IPO Glossary-Understand all IPO terms like GMP, DRHP, QIB, RII, Oversubscription in simple language.